Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03109314 · ClinicalTrials.gov registry record · Phase 4
Combining Donepezil With Perceptual Learning in Normal and Amblyopic Human The Effect of Donepezil on Perceptual Learning in Adult Amblyopia
A Phase 4 study of Amblyopia, sponsored by Dennis Levi.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03109314 is a Phase 4 study of Amblyopia that has completed, run by Dennis Levi. The registered enrollment target is 20 participants, below the 165-participant average among 24 other Amblyopia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03109314, a Phase 4 study of Amblyopia, has completed, sponsored by Dennis Levi.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The research deals with amblyopia or lazy eye, a condition that affects about 3% of the population, and results in a variety of visual deficits. Recent work suggests that there is limited neural plasticity in the visual system of adults with amblyopia. This study is aimed at understanding and increasing this plasticity. In this study, the investigators aim to understand how the amblyopic brain learns and how this process is affected by a drug called donepezil, which is sometimes given as a treatment for Alzheimer's disease. The investigators hope that this study will help to identify the chemical components that help the brain to learn, as well as the mechanism of amblyopia. The investigators also plan to test the normal periphery, as control.
Conditions Studied
Interventions
- DRUG Donepezil
- BEHAVIORAL Single-letter training
- BEHAVIORAL Uncrowd training
Study Locations (1)
California
- University of California, Berkeley - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-05-01 |
| Est. Completion | 2018-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03109314
The ClinicalTrials.gov registry entry for NCT03109314 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 165-participant average among 24 other Amblyopia trials with a reported enrollment target (88% lower). The listed sponsor is Dennis Levi, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 3 interventions - of which Donepezil is the first listed.
NCT03109314 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03109314 about?
NCT03109314 is a clinical study titled "Combining Donepezil With Perceptual Learning in Normal and Amblyopic Human The Effect of Donepezil on Perceptual Learning in Adult Amblyopia". The research deals with amblyopia or lazy eye, a condition that affects about 3% of the population, and results in a variety of visual deficits. Recent work suggests that there is limited neural plasticity in the visual system of adults with amblyopia. This study is aimed at understanding and increa...
What is the current status of trial NCT03109314?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2012-05-01. Estimated completion is 2018-12-01.
What conditions does trial NCT03109314 study?
This clinical trial studies the following conditions: Amblyopia.
What interventions are being tested in trial NCT03109314?
The interventions under investigation include: Donepezil (DRUG), Single-letter training (BEHAVIORAL), Uncrowd training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03109314?
This trial is sponsored by Dennis Levi, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03109314 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Noninvasive Brain Stimulation in Adult Amblyopia
RECRUITING · NA
-
OCT Eccentric Fixation and Amblyopia in Children
RECRUITING · NA
-
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
RECRUITING
-
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.